Literature DB >> 29578262

MicroRNA-guided gene expression in prostate cancer: Literature and database overview.

Olga E Bryzgunova1, Maria Yu Konoshenko1, Pavel P Laktionov1.   

Abstract

Insight into the aberrant expression of microRNAs (miRNAs) and the genes that they regulate during the progression of cancer in general and prostate cancer (PCa) in particular is one of the most important issues in current molecular biomedicine and allows for the discovery of therapeutic or diagnostic miRNA targets. The present study aimed to analyze the available data regarding the direct or indirect effects of miRNAs on the expression of the mRNAs involved in carcinogenesis and to enable updating and optimizing the selection of the corresponding targets. The present review focuses on the data related to the genes with miRNA-dependent expression during the development of PCa. The data used in this review have been extracted from research papers and the databases STRING, PANTHER and TargetScan, with a special focus on the genes directly associated with cell transformation and the maintenance of the transformed genotype, as well as tumor invasion and spread. The search for miRNA markers of PCa and therapeutically active molecules should rely on bioinformatics resources, such as data from recent experimental studies, as well as meta-analysis and cross-analysis of the data on the state of the tumor, patient status, histological/immunohistological data and data on mRNA-miRNA coexpression.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  gene expression; oncology; prostate cancer

Mesh:

Substances:

Year:  2018        PMID: 29578262     DOI: 10.1002/jgm.3016

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  5 in total

1.  miR-1303 promotes the proliferation, migration and invasion of prostate cancer cells through regulating the Wnt/β-catenin pathway by targeting DKK3.

Authors:  Bo Liu; Weidong Zhou; Huiyang Jiang; Zhendong Xiang; Lei Wang
Journal:  Exp Ther Med       Date:  2019-10-23       Impact factor: 2.447

2.  The Panel of 12 Cell-Free MicroRNAs as Potential Biomarkers in Prostate Neoplasms.

Authors:  Maria Yu Konoshenko; Evgeniy A Lekchnov; Olga E Bryzgunova; Ivan A Zaporozhchenko; Sergey V Yarmoschuk; Oksana A Pashkovskaya; Svetlana V Pak; Pavel P Laktionov
Journal:  Diagnostics (Basel)       Date:  2020-01-10

3.  Cationic Polymer Nanoparticles-Mediated Delivery of miR-124 Impairs Tumorigenicity of Prostate Cancer Cells.

Authors:  Raffaele Conte; Anna Valentino; Francesca Di Cristo; Gianfranco Peluso; Pierfrancesco Cerruti; Anna Di Salle; Anna Calarco
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

4.  MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1.

Authors:  Kai Cheng; Lan Feng; Shuang Yu; Changhong Yu; Nannan Chi
Journal:  Onco Targets Ther       Date:  2019-12-31       Impact factor: 4.147

Review 5.  The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer.

Authors:  Daniel J Turnham; Nicholas Bullock; Manisha S Dass; John N Staffurth; Helen B Pearson
Journal:  Cells       Date:  2020-10-22       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.